Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The German Hemophilia Registry: Growing with Its Tasks.
Duda H, Hesse J, Haschberger B, Hilger A, Keipert C. Duda H, et al. Among authors: hilger a. J Clin Med. 2020 Oct 24;9(11):3408. doi: 10.3390/jcm9113408. J Clin Med. 2020. PMID: 33114325 Free PMC article.
The growing number of hemophilia registries: Quantity vs. quality.
Keipert C, Hesse J, Haschberger B, Heiden M, Seitz R, van den Berg HM, Hilger A; ABIRISK Consortium. Keipert C, et al. Among authors: hilger a. Clin Pharmacol Ther. 2015 May;97(5):492-501. doi: 10.1002/cpt.83. Epub 2015 Apr 3. Clin Pharmacol Ther. 2015. PMID: 25669198 Review.
Response to Italian registries on bleeding disorders.
Keipert C, Hilger A. Keipert C, et al. Among authors: hilger a. Clin Pharmacol Ther. 2016 Mar;99(3):273. doi: 10.1002/cpt.314. Epub 2016 Jan 12. Clin Pharmacol Ther. 2016. PMID: 26663259 No abstract available.
Heterogeneity in COVID-19 Convalescent Plasma Clinical Trials.
Müller-Olling M, Vahlensieck U, Hilger A. Müller-Olling M, et al. Among authors: hilger a. Clin Pharmacol Ther. 2022 May;111(5):995-1000. doi: 10.1002/cpt.2281. Epub 2021 Jun 17. Clin Pharmacol Ther. 2022. PMID: 34139028 Free PMC article. No abstract available.
Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies.
Peyvandi F, Berger K, Seitz R, Hilger A, Hecquet ML, Wierer M, Buchheit KH, O'Mahony B, Bok A, Makris M, Mansmann U, Schramm W, Mannucci PM. Peyvandi F, et al. Among authors: hilger a. Haematologica. 2020 Aug;105(8):2038-2043. doi: 10.3324/haematol.2019.242735. Epub 2020 May 28. Haematologica. 2020. PMID: 32467138 Free PMC article.
175 results